Knowledge Center
Practical guides for formulators and procurement managers: ingredient comparisons, quality verification, regulatory updates.
A market intelligence report on the NAD⁺ supplement landscape in 2025 — NMN regulatory update, NMN vs NR dynamics, emerging ingredients (NRHM, S-Equol, CDP-Choline stacks), and quality sourcing trends.
Read article →Technical guide to NMN stability testing: degradation pathways, ICH Q1A protocol, packaging recommendations, and formulation-specific tips for capsule, tablet, powder, and liquid.
Read article →A practical regulatory and logistics guide for procurement managers importing NMN, CDP-Choline, and other nutraceutical ingredients from China to US, EU, and APAC markets.
Read article →What is NRHM (Nicotinamide Riboside Hydrogen Malate), how it differs from NR Chloride, its stability advantages, and formulation guidance.
Read article →A formulator guide to fermentation-derived S-Equol — why pure S-form outperforms racemic plant extracts, clinical applications by target market, and formulation tips.
Read article →A technical comparison of CDP-Choline and Alpha-GPC for nootropic formulators — covering choline content, BBB penetration, clinical evidence, and cost.
Read article →A practical due-diligence framework for procurement managers evaluating NMN and NAD⁺ raw material suppliers — beyond price and purity claims.
Read article →What to look for in an NMN COA, which analytical methods actually matter, and the red flags that signal a low-quality supplier.
Read article →A head-to-head technical comparison of NMN and NR for nutraceutical and pharmaceutical formulators — covering bioavailability, stability, purity targets, and regulatory status.
Read article →Scan to add WeChat
Alex Huang · Mon–Fri 9am–6pm CST